Y Intercept Hong Kong Ltd decreased its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS - Free Report) by 42.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 64,428 shares of the company's stock after selling 47,551 shares during the quarter. Y Intercept Hong Kong Ltd owned about 0.13% of Nu Skin Enterprises worth $444,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in NUS. Jane Street Group LLC increased its stake in shares of Nu Skin Enterprises by 358.4% in the 3rd quarter. Jane Street Group LLC now owns 924,993 shares of the company's stock worth $6,817,000 after acquiring an additional 723,220 shares during the last quarter. Weiss Asset Management LP acquired a new stake in Nu Skin Enterprises during the third quarter worth about $2,727,000. Walleye Capital LLC increased its position in Nu Skin Enterprises by 335.3% during the third quarter. Walleye Capital LLC now owns 289,236 shares of the company's stock worth $2,132,000 after purchasing an additional 222,793 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Nu Skin Enterprises by 175.6% during the third quarter. JPMorgan Chase & Co. now owns 231,957 shares of the company's stock worth $1,710,000 after purchasing an additional 147,784 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC boosted its holdings in Nu Skin Enterprises by 27.7% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 603,555 shares of the company's stock valued at $4,448,000 after purchasing an additional 130,980 shares during the last quarter. Institutional investors and hedge funds own 82.84% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. StockNews.com upgraded Nu Skin Enterprises from a "hold" rating to a "buy" rating in a research report on Tuesday, February 25th. DA Davidson reduced their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a "neutral" rating on the stock in a research note on Friday, December 20th.
Check Out Our Latest Stock Report on NUS
Nu Skin Enterprises Stock Down 3.2 %
Shares of NYSE:NUS traded down $0.25 during trading on Monday, hitting $7.67. The company's stock had a trading volume of 602,029 shares, compared to its average volume of 811,658. Nu Skin Enterprises, Inc. has a fifty-two week low of $5.95 and a fifty-two week high of $14.04. The company has a market capitalization of $381.38 million, a PE ratio of -2.60 and a beta of 1.17. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.17 and a current ratio of 1.82. The business has a 50 day moving average price of $6.97 and a two-hundred day moving average price of $7.25.
Nu Skin Enterprises (NYSE:NUS - Get Free Report) last announced its quarterly earnings data on Thursday, February 13th. The company reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.24 by $0.14. Nu Skin Enterprises had a negative net margin of 8.46% and a positive return on equity of 5.86%. The company had revenue of $445.55 million for the quarter, compared to the consensus estimate of $441.10 million. As a group, research analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current fiscal year.
Nu Skin Enterprises Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 5th. Shareholders of record on Monday, February 24th will be issued a dividend of $0.06 per share. The ex-dividend date of this dividend is Monday, February 24th. This represents a $0.24 dividend on an annualized basis and a yield of 3.13%. Nu Skin Enterprises's payout ratio is currently -8.14%.
Nu Skin Enterprises Profile
(
Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.